Compounds > idarubicinol
Page last updated: 2024-09-02

idarubicinol and Neoplasms

idarubicinol has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camaggi, CM; Carisi, P; Efthymiopoulos, C; Guaraldi, M; Martoni, A; Pannuti, F; Strocchi, E; Strolin-Benedetti, M; Tononi, A1
D'Incalci, M; Erranti, D; Freshi, A; Tirelli, U; Zanette, L; Zucchetti, M1

Trials

1 trial(s) available for idarubicinol and Neoplasms

ArticleYear
Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover study.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:4

    Topics: Administration, Oral; Biological Availability; Daunorubicin; Glycosylation; Humans; Idarubicin; Infusions, Intravenous; Kidney; Kidney Diseases; Liver Neoplasms; Neoplasms

1992

Other Studies

1 other study(ies) available for idarubicinol and Neoplasms

ArticleYear
Pharmacokinetics of 4-demethoxydaunorubicin in cancer patients.
    Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:6

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Biological Availability; Daunorubicin; Female; Half-Life; Humans; Idarubicin; Injections, Intravenous; Male; Middle Aged; Neoplasms

1990